Tech Company Financing Transactions
Synthorx Funding Round
Synthorx, operating out of La Jolla, secured $3.1 million in investment from Avalon Ventures and Correlation Ventures.
Transaction Overview
Company Name
Announced On
6/30/2014
Transaction Type
Venture Equity
Amount
$3,125,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
11099 North Torrey Pines Rd. 290
La Jolla, CA 92037
USA
La Jolla, CA 92037
USA
Phone
Website
Email Address
Overview
Synthorx is a biotechnology company using synthetic biology to discover and develop novel therapeutics, diagnostics and vaccines.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Laura Shawver
Chief Scientific Officer
Marcos Milla
Chief Scientific Officer
Floyd Romesberg
Browse more venture capital transactions:
Prev: 6/30/2014: Sportsvite venture capital transaction
Next: 6/30/2014: InboundWriter venture capital transaction
Share this article
News on VC Transactions
We document every notable VC transaction. VC transactions on this site come from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs